Total synthesis as a resource in the discovery of potentially valuable antitumor agents: cycloproparadicicol.
Total synthesis as a resource in the discovery of potentially valuable antitumor agents: cycloproparadicicol.
复制标题
DOI:
10.1002/anie.200390329
复制
发表时间:
2003-03
影响因子:
--
通讯作者:
Kana Yamamoto;R. Garbaccio;S. Stachel;D. Solit;G. Chiosis;N. Rosen;S. Danishefsky
中科院分区:
文献类型:
--
作者:
Kana Yamamoto;R. Garbaccio;S. Stachel;D. Solit;G. Chiosis;N. Rosen;S. Danishefsky
Hsp90 is a molecular chaperone required for the refolding of proteins in cells exposed to environmental stress. It governs the conformational maturation of a subset of proteins critical in regulating mitotic signal transduction and cellular survival.[1] These client proteins include steroid receptors, transcription factors, mutant p53, Hif1a, soluble kinases such as Akt, Raf-1, transmembrane kinases such as HER2, as well as cdk4 protein kinases. Hsp90 contains an ATP-binding pocket in its amino terminus. Several natural products, including geldanamycin, herbimycinA, and radicicol bind to this pocket and inhibit its chaperone function. This inhibition is mirrored in enhanced intracellular proteasomal degradation of Hsp90 client proteins. An encouraging consequence of this effect is an attenuation in the proliferation of cancer cells. In animal models, geldanamycin congeners exhibit antitumor activity at nontoxic doses.[2] The novel mechanism of action of geldanamycin-related drugs and the demonstration that they have, in principle, exploitable in vivo therapeutic indices have served to heighten interest in Hsp90 as a target for oncology.[3, 4]Radicicol (1),[5] originally isolated from M. bonorden, has a high affinity for Hsp90 (Kd= 20 nm) and is particularly potent in inhibiting its functions.[6] However, translation of the very promising in vitro profiles of radicicol and radicicol oxime to the in vivo realm has not been accomplished,[7] apparently as a result of unfavorable pharmakokinetics and nonspecific toxicities.